Health research
Hide menu
- Research overview
- Research Governance
- Ethics
- Data access
- Responsibilities of NT Health Site Principal Investigators and Endorsers
- Non-NT Health staff and students
- Fee schedules
- Submissions for new research
- Education and Training
- Australian Teletrial Program – Northern Territory
- NT Health clinical trials register
- Contacts
NT Health clinical trials register
Active Teletrials in NT
Study short title/ acronym | Health condition | Study full title | Link to ANZCTR/ clinicaltrials.gov | Site principal investigator | Primary site | Satellite sites |
---|---|---|---|---|---|---|
AGILE-Echo | Heart Failure / Valve Heart Disease | Use of Artificial intelligence-Guided echocardiography to assIst cardiovascuLar patient managEment | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=21108&isClinicalTrial=True | Dr Angus Baumann | Alice Springs Hospital | Ti Tree CHC Hermannsburg CHC Tennant Creek Hospital |
ASCEND | Pancreatic Cancer | A Randomised, double-blinded phase II study of gemcitabine and nab-paclitaxel with CEND-1 or placebo in patients with untreated metastatic pancreatic ductal adenocarcinoma | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382607&isReview=true | Dr Michail Charakidis | The Queen Elizabeth Hospital, SA | Royal Darwin Hospital |
MEGA-ROX | Critical Illness / Emergency Medicine | The Mega Randomised Registry Trial Comparing Conservative vs. Liberal OXygenation Targets | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379432&isReview=true | Dr Lewis Campbell Dr Paul Secombe | Royal Darwin Hospital | Alice Springs Hospital |
Pre-ANVU | Vulvar cancer | Feasibility of Groin Ultrasound to Predict Groin Lymph Node Involvement in Patients with Histologically Proven Vulvar Cancer and Feasibility of biomarker discovery in the differential diagnosis of VIN versus invasive vulvar cancer | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=384233&isReview=true | Dr Michelle Harris | Royal Brisbane and Women’s Hospital | Royal Darwin Hospital |
SELECT-SLE | Systemic Lupus Erythematosus | A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects With Moderately to Severely Active SLE | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=21246&isClinicalTrial=True | Dr Ju Ann Tan | The Queen Elizabeth Hospital, SA | Royal Darwin Hospital |
SOCRATES HCC | Early Hepatocellular Carcinoma | A randomised controlled trial of Standard Of Care versus RadioAblaTion in Early Stage HCC | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381818&isReview=true | Dr Kirsty Campbell | Flinders Medical Centre, SA | Royal Darwin Hospital |
TELEKINESIS | Kidney Nutrition | The Telenutrition and Kidney Health Study. A randomised controlled trial comparing the effect of providing nutrition support and advice using digital health to standard care on serum phosphate control in patients on dialysis | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=381780&isReview=true | Rachael Smalley | Alice Springs Hospital | Royal Darwin and Palmerston Hospital Tennant Creek Hospital |
TRITON | Necrotising soft-tissue infection | A Feasibility Trial of Tranexamic Acid for Necrotising Soft-tissue Infections | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382739&isReview=true | Dr Tejinder Mettho | Alfred Hospital, Vic | Royal Darwin Hospital |
Showing 1 to 8 of 8 entries
Active clinical trials in NT
Study short title/ acronym | Health condition | Study full title | Link to ANZCTR/ clinicaltrials.gov | Site principal investigator |
---|---|---|---|---|
ACT-2 | Cardiovascular/Type 2 Myocardial Infarction (MI) | The Appropriateness of Coronary investigation in myocardial injury and Type 2 myocardial infarction | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374157&isReview=true | Dr Hussam Tayeb |
AMLM22 (IAPC) | Acute myeloid leukaemia (AML) | The International AML Platform Consortium (IAPC) Trial | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12619000248167 | Dr Sunthanthira Ramamoorthy |
ARiSE Fluids | Septic shock | Australian Resuscitation in Sepsis Evaluation: Fluid or vasopressors in Emergency Department Sepsis | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=19156&isClinicalTrial=True | Dr Sandra Brownlea |
ARROW | Recurrent Wheeze/ respiratory | Assessing the Reduction of Recurrent admissions with OM-85 for preschool Wheeze | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380570&isReview=true | Dr Kathryn Roberts |
ASCOLT | Colorectal Cancer | Aspirin for Dukes C and High Risk Dukes B Colorectal Cancer. An International, Multi centre, Double Blind, Randomised, Placebo Controlled Phase III Trial. | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=365996&isReview=true | Dr Narayan Karanth |
ASCOT | COVID-19 (SARS-CoV-2) | Australasian COVID-19 Trial: A multi-centre randomised clinical trial to assess clinical, virological and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care. | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=379542&isReview=true | Dr Jane Davies |
AusHep | Chronic HBV, HCV, and HIV infections | Australian Hepatitis and risk survey in prisons | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=21244&isClinicalTrial=True | Priscilla Moore |
Azithromycin at birth | Maternal post-natal/infant infections | Single dose azithromycin shortly before birth to reduce infection in Aboriginal mothers and babies: a randomised controlled trial | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=387234&isReview=true | Dr Peter Morris |
BALANCE | Urinary Tract Infection/Urinary Sepsis/Bacteraemia | Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: Randomized Controlled Trial | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380457&isReview=true | Dr Catherine Marshall |
BCT-CAPTURE | Advanced Breast Cancer | A phase II randomised study to evaluate alpelisib plus fulvestrant versus capecitabine in oestrogen receptor-positive, HER2-negative advanced breast cancer patients with PIK3CA mutant circulating DNA | https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=377949&isReview=true | Dr Narayan Karanth |
Showing 1 to 10 of 76 entries
For closed clinical trials view the list of closed clinical trials.
More information
If you have any queries in regards to any of the below clinical trials, phone NT Health Research Governance Office (RGO) on 08 8922 7561 or email nthealth.rgo@nt.gov.au.
Note: Some of the trials listed are conducted by partnering institutions. If you do not see your clinical trial listed in here, contact us.
Print all pages in this section
Give feedback about this page.
Share this page:
URL copied!